Greenwich LifeSciences’ GLSI-100 Receives FDA Fast Track Designation for Preventing Breast Cancer Recurrence

Greenwich LifeSciences’ GLSI-100 Receives FDA Fast Track Designation for Preventing Breast Cancer Recurrence

Giuseppe Curigliano: The Path to A Successful Career

Giuseppe Curigliano

PRODIGE-13 Trial Results: Do We Really Need 5 Years of CT and CEA Follow-Up in CRC?

PRODIGE-13 Trial Results: Do We Really Need 5 Years of CT and CEA Follow-Up in CRC?

Florian Scotté: Fast-Track Safety Evaluation in Anticancer Drug Development

Florian Scotté

Michelle Mitchell Welcomes Pete Markey as CRUK’s New Executive Director

Michelle Mitchell

Vivek Subbiah: Why Traditional RCT-focused Reviews May Miss the Mark in Precision Medicine Era

Vivek Subbiah, Future of Cancer Treatment

Arndt Vogel: Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer

Arndt Vogel

Ophira Ginsburg: Thrilled to join Imperial College London’s School of Public Health

Ophira Ginsburg

OncoCalendar

« All Events

  • This event has passed.

Refresher course for diagnosis and management of early-stage lung cancer by ESO

March 20 • 6:00 PM - March 22 • 12:00 PM
Refresher course for diagnosis and management of early-stage lung cancer by ESO

Refresher course for diagnosis and management of early-stage lung cancer by ESO will be held at Belgrade, Serbia from March 20-22, 2025.

This course is designed to provide a comprehensive understanding of the latest diagnostic and therapeutic approaches in the diagnosis and management of early-stage lung cancer. The primary goal is to enhance multidisciplinary collaboration between respiratory physicians, thoracic surgeons, and oncologists to ensure accurate diagnosis, staging, and the development of individualized treatment plans. Emphasizing the latest advancements in imaging techniques, biopsy procedures, molecular testing, oncology, and surgical management, the course will equip participants with the essential skills to accurately assess and treat early-stage lung cancer. This will ensure that patients receive timely, targeted, and effective interventions.

The course aims to deepen participants’ knowledge of both surgical and non-surgical treatment options. This includes minimally invasive techniques, stereotactic body radiotherapy (SBRT), and the role of adjuvant therapies. By incorporating case-based learning and evidence-based guidelines, the course will help foster a patient-centered approach to care. This approach emphasizes the importance of shared decision-making and long-term follow-up for improving patient outcomes. The ultimate goal is to empower physicians to optimize treatment outcomes, reduce recurrence rates, and enhance patient survival and quality of life.

Details

Start:
March 20 • 6:00 PM
End:
March 22 • 12:00 PM
Website:
https://www.eso.net/en/what-we-do/future-events/refresher-course-on-early-lung-cancer/3-6592-0-?utm_source=social&utm_medium=banner&utm_campaign=RefresherLung

Organizer

European School of Oncology
Phone
+41 91 820 09 50
Email
eso@eso.net
View Organizer Website

Venue

Belgrade
Belgrade, Serbia + Google Map